Quick Answer
BioCorRx Inc. reported Operating Income of -$4.83 million for fiscal year 2025.
BioCorRx Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.83M | +5.7% |
| 2024 | -$5.12M | -35.2% |
| 2023 | -$3.79M | +19.4% |
| 2022 | -$4.70M | +14.7% |
| 2021 | -$5.51M | +26.5% |
| 2020 | -$7.49M | -34.7% |
| 2019 | -$5.56M | -20.2% |
| 2018 | -$4.63M | -60.0% |
| 2017 | -$2.89M | -32.5% |
| 2016 | -$2.18M | +57.4% |
| 2015 | -$5.12M | -67.7% |
| 2014 | -$3.05M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.95M | -17.2% | -37.6% |
| June 30, 2025 | -$1.41M | -3.3% | -50.7% |
| March 31, 2025 | -$937.9K | +3.2% | +43.5% |
| September 30, 2024 | -$1.66M | -72.6% | -21.2% |
| June 30, 2024 | -$1.37M | -44.6% | -41.4% |
| March 31, 2024 | -$968.7K | +8.3% | -0.7% |
| September 30, 2023 | -$961.9K | +6.5% | -1.6% |
| June 30, 2023 | -$946.9K | +30.3% | +10.4% |
- BioCorRx Inc. showed an increase of +5.7% in Operating Income compared to the prior fiscal year.
- Over the 2014–2025 period, BioCorRx Inc.’s operating income has declined by 58.3% (from -$3.05 million to -$4.83 million).
- The most recent figure is from BioCorRx Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: